MARKET

NTHI

NTHI

NeOnc Technologies Holdings Inc
NASDAQ
3.650
-0.420
-10.32%
Opening 14:33 09/09 EDT
OPEN
4.000
PREV CLOSE
4.070
HIGH
4.000
LOW
3.460
VOLUME
250.35K
TURNOVER
--
52 WEEK HIGH
12.99
52 WEEK LOW
3.005
MARKET CAP
94.67M
P/E (TTM)
-1.7090
1D
5D
1M
3M
1Y
5Y
1D
NeOnc Technologies Prices $15M Registered Direct Offering With Institutional Investors
NASDAQ · 5h ago
Press Release: NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data
Dow Jones · 8h ago
NeOnc Technologies prices 3.57M shares at $4.20 in registered direct offering
TipRanks · 9h ago
NeOnc Technologies Enters $15M Securities Purchase Agreements In At‑The‑Market Offering
Benzinga · 9h ago
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data
Barchart · 13h ago
NeOnc Technologies Price Target Maintained With a $15.00/Share by BTIG
Dow Jones · 1d ago
BTIG Reiterates Buy on NeOnc Technologies Hldgs, Maintains $15 Price Target
Benzinga · 1d ago
Weekly Report: what happened at NTHI last week (0831-0904)?
Weekly Report · 2d ago
More
About NTHI
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on establishing treatments for intracranial malignancies, such as aggressive cancers located in the brain. It is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. It is developing novel drug delivery methods to be used in combination with novel drug candidates. The Company has two lead products in development: NEO100 and NEO212. NEO100 is a purified form of perillyl acid (POH) which is administered to brain cancer patients via intranasal delivery. NEO212 is a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol. NEO212 is undergoing development towards intranasal application specifically for patients with uncontrolled brain metastases derived from peripheral tumors (lung, breast, skin, and others).

Webull offers Neonc Technologies Holdings Inc stock information, including NASDAQ: NTHI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTHI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTHI stock methods without spending real money on the virtual paper trading platform.